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Abstract
Background: Heparin saline (HS) is theoretically superior to normal saline (NS) for maintaining the patency of
central venous catheters (CVCs), but the comparative efficacy of them remains controversial. The aim of this
systematic review and meta-analysis was to assess the efficacy of NS versus HS in the maintenance of the patency
of CVCs in adult patients.
Methods: We searched PubMed, Embase and the Cochrane library databases. Randomized controlled trials (RCTs)
evaluating the use of NS vs. HS to maintain the permeability of CVCs among adult patients were included in our
meta-analysis. References of relevant papers were reviewed manually. No language restriction was applied. Non-
human studies were excluded. Pooled relative risk (RR) was calculated using a Mantel-Haenszel random-effects
model. We also performed subgroup analysis examining the effect of the duration of catheter placement on the
outcome. All statistical tests were two-sided using a significance level of 0.05.
Results: Ten RCTs involving 7875 subjects (with analysis at patient, catheter, lumen and line access level) were
included in this meta-analysis. Whether in terms of pooled or local analysis (RR with 95% confidence interval spans 1),
NS can be equally, if not more effective, in keeping the CVCs open. Of studies reporting secondary outcomes
(maneuver needed, heparin-induced thrombocytopenia, haemorrhage, central venous thrombosis and catheter-related
bloodstream infection), heparinised saline was shown not to be superior to non-heparinised solution. Subgroup
analysis in patients with short vs long term CVC placement was consistent with the main outcome partly and in
particular for maintenance of catheter patency in patients with a long-term placement i.e. >30 days, the RR was 0.97
(n = 6589; 95% CI = 0.76 to 1.23; P = 0.796). However, for patients in whom the catheter was in place for <30 days, the
RR was 1.52 (n = 1286; 95% CI = 1.02 to 2.27; P = 0.041).
Conclusions: Based on the results of this meta-analysis, HS is not superior to NS in reducing CVCs occlusion. But in the
short term, the use of HS is slightly superior to NS for flushing catheters from a statistical point of view.
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Background
Central venous catheters (CVCs) are widely utilized in
clinical practice, especially in intensive care units (ICUs)
[1]. These devices are inserted so as to enable the
administration of fluids, blood products, medications,
parenteral nutrition, and for the performance of dialysis
and central venous pressure monitoring [2, 3]. Currently,
there are four types of CVCs: non-tunneled, tunneled,
peripherally nserted central catheters (PICCs) and totally
implantable venous access devices (TIVADs) [4].
These central lines will remain in place for days or
even weeks each time [5]. Prolonged use may result in
catheter occlusion, which may give rise to a requirement
for the catheter to be treated, removed or replaced.
Inserting a new central line creates latent threats, which
could lead to disrupted treatment, increasing morbidity,
and greater spending on health care [5]. Generally,
catheter obstruction can be defined as partial occlusion
(inability to aspirate blood but ability to flush freely) or
complete occlusion (inability to flush freely and with-
draw blood). It is estimated that the occlusion rate is be-
tween 0% and 33% when using heparin saline (HS)
solution [6, 7]. Factors leading to catheter obstruction
can be generally classified into three categories: mechan-
ical causes, drug/mineral precipitates and clot formation,
which is the most common reason overall [8]. To avoid
the risk of catheter occlusion, thrombosis and catheter-
related bloodstream infection (CRBSI), proper catheter
flushing and locking are always considered to be the pri-
mary intervention because of the effect of reducing
blood reflux into the lumen [8, 9].
Unfractionated heparin is well-known for its anticoagu-
lant activity. Thus, heparin is widely used to maintain the
patency of CVCs [10]. Nonetheless, the efficacy of this
practice has not been definitively shown. Moreover, the
use of heparinised saline is associated with potential risks
such as coagulation disorders, hypersensitivity reactions
and heparin-induced thrombocytopenia (HIT) [11, 12].
Researchers have been looking for a safe alternative to
heparin, such as isotonic saline, vitamin C, lepirudin,
sodium citrate or polygeline, to improve this situation
[13–16]. Especially important, if there was a suitable re-
placement for HS, that would be beneficial, especially for
patients with contraindications to using HS.
There have been numerous publications in this field
over the last few years, including a guideline [17], several
trials [2, 10] and several reviews [5, 9], including a
Cochrane Review [18]. Most of these studies indicate that
normal saline (NS) is safe and efficacious in preventing
catheter occlusion in adult populations with CVCs. The
recent guideline concluded that routine flushing with NS
is recommended. However, the Cochrane review showed
that there is no clear evidence to indicate whether NS
flushing is superior to flushing with HS solution.
CVC occlusion is a fairly common problem, but differ-
ences in methods of prophylaxis, diagnosis and treatment
practices related to catheter lumen obstruction vary, per-
haps as a result of a lack of appropriate clinical guidelines
[19]. An evidence-based, standardized flushing protocol is
required for CVCs in adults. We conducted a systematic
review and meta-analysis to evaluate the clinical efficacy
(benefits and harms) of NS flushes and HS flushes for pre-
vention of CVC lumen occlusion in adult patients.
Methods
Our systematic review and meta-analysis was conducted ac-
cording to preferred reporting items for systematic reviews
and meta-analyses (PRISMA) guidelines (Additional file 1)
[20]. The PICO framework was applied to define the clinical
question clearly (Additional file 2). The primary outcome
was catheter occlusion. Secondary outcomes included: man-
euver needed (patients who required catheter manipulation
to maintain the patency of the lumen), HIT, haemorrhage,
central venous thrombosis and CRBSI.
Search strategy and selection criteria
We systematically searched PubMed, Embase and the
Cochrane library databases from the inception to 28
September 2016, using the following terms: “Sodium
Chloride”, “Saline Solution, Hypertonic”, “NaCl”,
“Heparin”, “Catheterization, Central Venous”, “Random-
ized Controlled Trial”, etc. (Additional file 3). There was
no restriction on language. We also reviewed bibliograph-
ies in the retrieved articles to identify additional relevant
studies. Only clinical randomized controlled trials (RCTs)
of NS flushing vs flushing with HS solution in adults were
included. Exclusion criteria were (1) age <18 years, and (2)
case reports, letters, reviews, case-control studies and co-
hort studies, or non-human studies.
Data extraction
Data were independently extracted by three reviewers
(ZL, YY and WX). The following information was ab-
stracted from the included studies: Study ID, mean age
(years), country origin, number of subjects (NS/HS), fe-
male (%), centre, ICUs, disease types, follow up (days),
heparin concentration (IU/ml) and heparin volume (ml).
Disagreements were resolved by consensus.
Assessment of study quality
The quality of the individual studies was assessed based
on the Cochrane handbook for systemic reviews of inter-
ventions [21].
Assessment of risk of bias
We performed sensitivity analysis to assess the influence of
a single study on the pooled effects. Simultaneously, we used
a funnel plot for assessment of publication bias [22].
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Statistical analysis
The pooled effects were analyzed by relative risk (RR)
with 95% confidence interval (CI) for dichotomous
outcomes. Statistical heterogeneity among trials was
quantitatively assessed with the X2 test, P values and the
I2 statistics [23]. We pooled data using Mantel-Haenszel
random-effects models, which are more conservative in
their estimations [24].
During the search process, there were four different
kinds of subjects for analysis: patients (six studies), cath-
eters (two studies), lumens (one study; multilumen
CVCs) and line access (one study; flushing central lines
before and after each use). Given this, our meta-analysis
was to be analysed separately on the basis of definite
features of units.
In light of the Ge and Schallom study [2, 25], the dur-
ation of catheter placement is classified as short-term
(less than 3–4 wks) and long-term (months to years).
Simultaneously, subgroup analysis based on the length
of indwelling time was carried out to characterize pos-
sible sources of heterogeneity(e.g. <30 and >30 days). All
statistical tests were two-sided using an α level of 0.05.
This meta-analysis was conducted using Stata 12.0 soft-
ware (StataCorp, College Station, TX, USA) and Review
Manager Version 5.3.5 (available from http://tech.co-
chrane.org/revman/download).
Results
Search results and study characteristics
The chart for the selection process and detailed informa-
tion is given in Fig. 1. The literature search yielded 542
publications up to 28 September, 2016. We excluded 532
articles during the screening process. Thus, a total of 10
studies were eligible according to the inclusion criteria.
The 10 studies were from Germany [13] (n = 1), Spain
[6] (n = 1), Belgium [26] (n = 1), Italy [27] (n = 1), Japan
[28] (n = 1), Iran [29, 30] (n = 2) and the USA [2, 31, 32]
(n = 3). As a result, the 10 trials, including four ICU and
six non-ICU studies, were reported in the years 2002–
2015 and the average duration of follow up ranged from
1 to 400 days. The average age of the patients ranged
from 51.6 to 68.43 years, and the proportion of female
patients ranged from 31% to 65.34%. The different con-
centrations of heparin recorded in the existing publica-
tions ranged from 10 IU/mL to 5000 IU/ml.
In the Lyons trial [31], a comparison of 0.9% NaCl
with two different concentrations of heparin (10 and
100U/ml) was presented. Consequently, we divided the
data into two sets and performed statistical analysis. Ul-
timately, our study yielded 11 datasets from 10 RCTs.
The baseline characteristics of the 10 eligible RCTs are
shown in Table 1.
Assessment of study quality
The risk of bias in the included studies is summarized in
Fig. 2. It indicated that two papers had high risk of bias
as they failed to obtain the expected sample size [6, 27],
and one study was subject to detection bias, as the out-
come measurement could have been influenced by lack
of blinding [27].
Assessment of reporting biases
We conducted sensitivity analysis, which suggested that
the Goossens [26] study was the main source of statis-
tical heterogeneity in our meta-analysis. However, we
found it complied completely with the inclusion stan-
dards. Examination of the funnel plot suggests that there
was also publication bias (Fig. 3).
The forest plot data prepared using Mantel-Haenszel
random-effects models is summarized in Table 2.
Synthesis of primary outcome
Pooled analysis was performed using a Mantel-Haenszel
random-effects model and reported as RR with 95% CI
(n = 7875; RR, 1.21; 95% CI = 0.91 to 1.61; P = 0.186),
with a low heterogeneity among these studies (X2 = 8.39,
P = 0.299; I2 = 16.6%).
From the catheter (n = 161; RR, 3.00; 95% CI = 0.89 to
10.10; P = 0.076), line access (n = 6126; RR, 0.92; 95% CI
= 0.71 to 1.19; P = 0.524), lumen (n = 709; RR, 1.66; 95%
CI = 0.85 to 3.24; P = 0.141) and patient (n = 879; RR,
1.33; 95% CI = 0.86 to 2.07; P = 0.205), HS is not superior
to NS in preventing catheter occlusion (Fig. 4).
Secondary outcomes
For maneuver needed (n = 196; RR, 1.24; 95% CI = 0.71
to 2.16; P = 0.457), heparin-induced thrombocytopenia
(n = 1263; RR, 1.33; 95% CI = 0.09 to 18.54; P = 0.834),
haemorrhage (n = 439; RR, 0.75; 95% CI = 0.32 to 1.74; P
= 0.501), central venous thrombosis (n = 1512; RR, 0.81;
95% CI = 0.50 to 1.31; P = 0.381) and catheter-related
Fig. 1 Flow chart of article selection procedure
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bloodstream infection (n = 1630; RR, 0.84; 95% CI = 0.11
to 6.71; P = 0.871), flushing CVCs with NS was as effect-
ive as HS (Fig. 5).
The results of subgroup analysis
There were seven studies examining the duration of
catheter placement at 30 days or less (n = 1286
subjects) and there were three studies examining
duration of catheter placement of more than 30 days
(n = 6589 subjects). Similar to the aforementioned, NS
was equal in efficacy to using HS solution in long-
term CVCs (n = 6589; RR, 0.97; 95% CI = 0.76 to 1.23;
P = 0.796). By comparison, for short-term study, this
analysis demonstrated that NS is less effective than
HS (n = 1286; RR, 1.52; 95% CI = 1.02 to 2.27; P =
0.041) (Fig. 6).
Table 1 Main characteristics of the included studies
















Rabe 2002 [13] 59.25 Germany 33/33 63.64 S Y Multi-disease 20 5000 0.5
Kaneko 2004 [28] 68.43 Japan 26/22 50.00 S N Nephropathy 48 1000 2
Pumarola 2007 [6] 52.27 Spain 57/38 31.60 M Y Multi-disease 3 100 5
Bowers 2008 [32] 54.36 USA 50/52 50.00 S N Multi-disease 10.3 100 3
Schallom 2012 [2] 58.69 USA 150/145 48.81 S Y Multi-disease 14 10 3
Goossens 2013 [26] 55.81 Belgium 404/398 65.34 S N Cancer patients 180 100 3
Beigi 2014 [29] 63.1 Iran 49/47 45.83 S N Multi-disease 1 100 …
Lyons 2014 [31] 52 USA 28/30 40 H N Multi-disease 23 10 5
Lyons 2014 [31] 52 USA 28/32 40 H N Multi-disease 23 100 3
Molin 2015 [27] 62.69 Italy 203/212 53.49 M N Cancer patients 400 50 5
Ziyaeifard 2015 [30] 51.6 Iran 50/50 31.00 S Y Cardiac surgery 3 10 5
S single-centre study, M multi-centre study, H home care patient, Y yes, N no
Fig. 2 Risk of bias assessment. a Risks of bias graph. b Risks of bias summary
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Discussion
Our systematic review and meta-analysis did not dem-
onstrate a general difference between use of NS or HS in
adult populations. In subgroup analysis, stratified by the
length of indwelling time (e.g. <30 and >30 days), there
appear to be two conflicting conclusions (Fig. 6.) In the
short run (<30 days), HS was slightly better than NS. A
plausible reason may be that NS has no anticoagulation
activity. However, a marginally significant association
was observed between using NS vs HS and the incidence
of catheter occlusion. Owing to the limited numbers of
included studies and the effect sizes, we should treat
such a result with caution. By comparison, NS could be
equal, if not more effective, in the long run (>30 days).
This has implications for patients in whom long-term
catheter use may be necessary, for example, in patients
undergoing cancer treatment or those requiring dialysis.
From a long-term perspective, the use of NS in these pa-
tients has several advantages over HS solutions. To
begin with, NS is an isotonic solution, which is in ac-
cordance with basic physiological needs. In addition, the
use of NS will result in fewer side effects from heparin-
related complications. Finally, as HS is several times
more expensive than NS [32], eliminating its use in
flushing solutions has economic benefits.
To date, there have only been three relevant meta-
analyses in this area (Additional file 4). The result of the
first study (network meta-analysis) was no marked dif-
ference, when comparing adult patients with NS vs HS
or other solutions in the flushing of CVCs [33]. The sec-
ond study, consistent with results of previous research,
found that HS was not more effective than NS in redu-
cing catheter occlusion when analysed in three different
areas (participant, catheter and line access) [18]. These
findings challenged the continued use of HS in CVC
flushing, as it is more expensive than saline solution.
However, a recent study supported NS as a substitution
for HS as a locking solution in CVCs in adult patients
from the point of view of four different types of CVC
[34]. Data from these studies suggests that HS may not
be required to maintain the patency of CVCs. In the ab-
sence of sufficient evidence to support the use of NS,
the debate will be moot. For this reason, further study is
needed in this field.
To our knowledge, our study might be the first meta-
analysis from the viewpoint of four different CVC-
related areas (patient, catheter, lumen and line access)
and indwelling time (i.e. <30 and >30 days). Our results,
in accordance with current studies, meta-analyses and
reviews [18, 27, 33], suggest that there is very little evi-
dence to conclude that flushing with HS has more effect
than NS flushing solution for CVC maintenance.
Only a few randomized controlled studies have com-
pared NS with HS for maintenance of CVC lumen pa-
tency in adults. The Rabe study was the first RCT to
compare the effects of NS versus HS and they deter-
mined that the use of a flush containing 5000 U/ml was
more effective than NS [13]. In particular, catheter sur-
vival rate was higher in the HS group than in NS group.
In contrast to the results of the Rabe study, a large num-
ber of other studies suggest that the catheter lumen oc-
clusion rate is not different between those with vs those
without heparin [10, 27–29]. NS flushing for CVCs has
been applied in some American ICUs without support-
ing evidence [35]. Parallel with the mainstream view,
Schiffer et al. [17] suggest that routine flushing of CVCs
with NS to prevent occlusion is reasonable in this guide-
line. Morover, a report of a recent multicentre
Fig. 3 Funnel plot was generally asymmetrical. The black dots and
dotted line indicate individual studies and 95% confidence
intervals, respectively
Table 2 The summary results of all 10 studies
Result Primary outcomes Secondary outcomes Subgroup
analysis
Pooled effect Catheter Line access Lumen Patient Maneuver needed HIT Haemorrhage CVT CRBSI Short Long
RR 1.21 3.00 0.92 1.66 1.33 1.24 1.33 0.75 0.81 0.84 1.52 0.97
95% CI lower-bound 0.91 0.89 0.71 0.85 0.86 0.71 0.09 0.32 0.50 0.11 1.02 0.76
95% CI upper-bound 1.61 10.10 1.19 3.24 2.07 2.16 18.54 1.74 1.31 6.71 2.27 1.23
P value 0.186 0.076 0.524 0.141 0.205 0.457 0.834 0.501 0.381 0.871 0.041 0.796
HIT heparin-induced thrombocytopenia, CVT central venous thrombosis, CRBSI catheter-related bloodstream infection, RR relative risk, CI confidence interval
Zhong et al. Critical Care  (2017) 21:5 Page 5 of 9
Fig. 4 Forest plot of association between use of normal saline (NS) vs heparin saline (HS) and the incidence of catheter occlusion. RR relative risk,
CI confidence interval, NS normal saline, HS heparin saline
Fig. 5 Forest plot of association between use of NS vs HS and the incidence of complications. RR relative risk, CI confidence interval, NS normal saline,
HS heparin saline
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randomized trial [27] argued that HS was not more ef-
fective than NS in reducing withdrawal or total occlu-
sion. No statistical difference in catheter patency was
observed when comparing NS to HS solution.
Due to the body’s physiologic response to the cathe-
ters, nearly 100% of CVCs will develop a “fibrin sheath”,
which may increase the risk of catheter occlusion from 1
to 14 days after insertion of the indwelling catheter [36,
37]. As the “fibrin sleeve” usually envelops the tip of the
CVC, some argue that a heparin lock could not prevent
thrombotic occlusion because of the difficulty in achiev-
ing an effective concentration on the outside of the cath-
eter tip [28]. Our findings support these suggestions.
Certainly, the occurrence of CVC occlusion is related
to the catheter type, puncture site, heparin concentra-
tion, heparin volume, flush frequency, retaining time
and the patient’s physical condition [37, 38]. As there
are indeterminate factors in this field, further studies, in-
cluding well-designed trials, are warranted to assess
these effects on clinical outcomes.
Various potential limitations should be taken into con-
sideration. First, although the statistical heterogeneity
was low, the clinical and methodological heterogeneity
cannot be ignored. The latter two types of heterogeneity
might be attributed to various types of participants, in-
terventions, outcomes studied (partial or complete oc-
clusion), study designs and study qualities. Second, the
potential hazards might occur after long-term follow up,
thus, some of these complications could be discarded
due to the short duration of some included studies.
Third, this meta-analysis was limited to studies con-
ducted in Asia, Europe and North America, and thus,
might not be generalizable to other parts of the world.
Finally, there was a publication bias in our study as small
studies with null results tend not to be published.
Hence, uniform study design and multi-centre studies
should be launched in different countries and regions to
establish the best approach to long-term maintenance of
CVCs.
Conclusions
So far, there are still no criteria for flushing and locking
techniques, volumes or regimens for safe CVC mainten-
ance. In conclusion, this meta-analysis did not demon-
strate any superiority of heparin locked saline solutions
over NS for the maintenance of CVC lumen patency in
adult patients. Thus, additional large prospective RCTs
might be needed in this field due to the inconclusive evi-
dence available.
Key messages
 Few RCTs have compared NS to HS for prevention
of catheter occlusion in adult patients.
 Pooling the results showed that flushing CVCs
with NS is as effective as HS in adult patients,
but the 95% confidence interval is wide and
spans 1.
 There is a lack of evidence of the effectiveness of NS
flushing compared to HS in keeping CVCs open.
Fig. 6 Subgroup analysis based on the duration of catheter placement. RR relative risk, CI confidence interval, NS normal saline, HS heparin saline
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